Genetic heterogeneity in lung and colorectal carcinoma as revealed by microsatellite analysis in plasma or tumor tissue DNA

Cancer

Volumn 97, Issue 9, 2003, Pages 2308-2317

  Beau Faller, Michèle ^a   Weber, Jean Christophe ^b   Schneider, Anne ^a   Guèrin, Eric ^a   Gasser, Bernard ^c   Ducrocq, Xavier ^c   Jaeck, Daniel ^b   Wihlm, Jean Marie ^c   Ouoix, Elisabeth ^c   Gaub, Marie Pierre ^a  

^a HÔPITAL DE HAUTEPIERRE   (France)

^b UNIVERSITY HOSPITAL OF STRASBOURG   (France)

^c HÔPITAL CIVIL   (France)

Author keywords

Allelotyping; Alternative allelic imbalance; Colorectal carcinoma; Lung carcinoma; Plasma DNA; Synchronous liver metastasis

Indexed keywords

MICROSATELLITE DNA;

ADULT; AGED; ALLELE; ARTICLE; BRONCHOSCOPY; CANCER GROWTH; CANCER MORTALITY; CANCER STAGING; CHROMOSOMAL LOCALIZATION; CLINICAL ARTICLE; COLORECTAL CARCINOMA; CONTROLLED STUDY; ELECTROPHORESIS; FEMALE; FOLLOW UP; GENETIC HETEROGENEITY; HUMAN; HUMAN TISSUE; LIVER METASTASIS; LUNG ADENOCARCINOMA; LUNG BIOPSY; LUNG CARCINOMA; LUNG NON SMALL CELL CANCER; LUNG SMALL CELL CANCER; LUNG SQUAMOUS CELL CARCINOMA; MALE; PLASMA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS;

ADENOCARCINOMA; ADULT; AGED; ALLELIC IMBALANCE; CARCINOMA, SMALL CELL; CARCINOMA, SQUAMOUS CELL; COLORECTAL NEOPLASMS; DISEASE PROGRESSION; DNA, NEOPLASM; FEMALE; GENE FREQUENCY; GENETIC HETEROGENEITY; HUMANS; LUNG NEOPLASMS; MALE; MICROSATELLITE REPEATS; MIDDLE AGED; POLYMERASE CHAIN REACTION; PROGNOSIS;

EID: 0344088472     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.11324     Document Type: Article

References (45)

1. Jackson AL, Loeb LA. On the origin of multiple mutations in human cancers. Cancer Biol. 1998;8:421-429.
2. Kinzler KW, Vogelstein B. Lessons from hereditary colorectal cancer. Cell. 1996;87:159-170.
3. Konishi N, Hiasa Y, Matsuda H, et al. Intratumor cellular heterogeneity and alterations in ras oncogene and p53 tumor suppressor gene in human prostate carcinoma. Am J Pathol. 1995;174:1112-1122.
4. Macintosh CA, Stower M, Reid N, Maitland NJ. e microdissetion of human prostate cancers reveals genotypic heterogeneity. Cancer Res. 1998;58:21-28.
5. Hori H, Miyake S, Akiyama Y, Endo M, Yuasa Y. Clonal heterogeneity in human esophageal squamous cell carcinomas on DNA analysis. Jpn J Cancer Res. 1996;87:923-929.
6. Jiang X, Morland SJ, Hichcock A, Thomas EJ, Campbell IG. Allelotyping of endometriosis with adjacent ovarian carcinoma reveals evidence of a common lineage. Cancer Res. 1998.58;1707-1712.
7. Sozzi G, Miozzo M, Pastorino U, et al. Genetic evidence for an independent origin of multiple preneoplastic and neoplastic lung lesions. Cancer Res. 1995;55:135-140.
8. Thiberville L, Payne P, Vielkinds J, et al. Evidence of cumulative gene losses with progression of premalignant epithelial lesions to carcinoma of the bronchus. Cancer Res. 1995;55:5133-5139.
9. Chung CTY, Sundaresan V, Hasleton P, Rudd R, Taylor R, Rabbitts PH. Clonal evolution of lung tumors. Cancer Res. 1996;56:1609-1614.
10. Mao L, Lee JS, Kurie JM, et al. Clonal genetic alterations in the lungs of current and former smokers. J Natl Cancer Inst. 1997;89:857-862.
11. Aoyagi Y, Yokose T, Minami Y, et al. Accumulation of losses of heterozygosity and multistep carcinogenesis in pulmonary adenocarcinoma. Cancer Res. 2001;61:7950-7954.
12. Nagel S, Borisch B, Thein SL, et al. Somatic mutations detected by mini- and microsatellite DNA markers reveal clonal intratumor heterogeneity in gastro-intestinal cancers. Cancer Res. 1995;55:2866-2870.
13. Baisse B, Bouzourene H, Sarage EP, Bosman FT, Benhattar J. Intratumor genetic heterogeneity in advanced human colorectal adenocarcinoma. Int J Cancer. 2001;93:346-352.
14. Park IW, Wistuba II, Maitra A, et al. Multiple clonal abnormalities in the bronchial epithelium of patients with lung cancer. J Natl Cancer Inst. 1999;91:1863-1868.
15. Skotheim RI, Diep CB, Kraggerud SM, Jakobsen KS, Lothe RA. Evaluation of loss of heterozygosity/allelic imbalance scoring in tumor DNA. Cancer Genet Cytogenet. 2001;127:64-70.
16. Pylkkänen L, Karjalainen A, Antitila S, Vainio H, Husgafvel-Pürsiainen K. No evidence of microsatellite instability but frequent loss of heterozygosity in primary resected lung cancer. Environ Mol Mutagen. 1997;30:217-223.
17. Endo C, Sagawa M, Sato M, et al. Sequential loss of heterozygosity in the progression of squamous cell carcinoma of the lung. Br J Cancer. 1998;78:612-615.
18. Virmani AK, Fong KW, Kodagoda D, et al. Allelotyping demonstrates common and distinct patterns of chromosomal loss in human lung cancer types. Genes Chromosomes Cancer. 1998;21:308-319.
19. Kohno H, Hiroshima K, Toyozaki T, Fujisawa T, Ohwada H. p53 mutations and allelic loss of chromosome 3p, 9p of preneoplastic lesions in patients with non-small cell lung carcinoma. Cancer. 1999;85:341-347.
20. Kohno T, Yokota J. How many tumor suppressor genes are involved in human lung carcinogenesis? Carcinogenesis. 1999;20:1403-1410.
21. Vogelstein B, Fearon ER, Kern SE, et al. Allelotype of colorectal carcinomas. Science. 1989;244:207-211.
22. Fearon ER. Molecular genetic studies of the adenocarcinoma sequence. Adv Intern Med. 1994;39:123-147.
23. Bardi G, Parada LA, Bomme L, et al. Cytogenetic comparisons of synchronous carcinomas and polyps in patients with colorectal cancer. Br J Cancer. 1997;76:765-769.
24. Meijer GA, Hermsen MA, Baak JP, et al. Progression from colorectal adenoma to carcinoma is associated with nonrandom chromosomal gains as detected by comparative genomic hybridization. J Clin Pathol. 1998;51:901-909.
25. Hanahan D, Weinberg RA. The hallmarks of cancer. Cell. 2000;100:57-70.
26. Sparks AB, Morin PJ, Vogelstein B, Kinzler KW. Mutational analysis of APC/beta-catenine/tcf pathway in colorectal cancer. Cancer Res. 1998;58:1130-1134.
27. Paredes-Zaglul A, Kang JJ, Essig YP, et al. Analysis of colorectal cancer by comparative genomic hybridization: evidence for induction of the metastatic phenotype by loss of tumor suppressor genes. Clin Cancer Res. 1998;4:879-886.
28. Stroun M, Lyautey J, Lederrey C, Mulcahy HE, Anker P. Alu repeat sequences are present in increased proportions compared to a unique gene in plasma/serum DNA. Ann N Y Acad Sci. 2002;945:258-264.
29. Zelen M. Keynote address on biostatistics and data retrieval. Cancer Chemother Rep. 1973;4:31-42.
30. Mountain CF. Revision in the international system for staging lung cancer. Chest. 1997;111:1710-1717.
31. American Joint Committee on Cancer (AJCC). Colon and rectum. In: Fleming ID, Cooper JS, Henson DE, et al., editors. AJCC cancer staging manual, 5th ed. Philadelphia: Lippincott-Raven Publishers, 1997:83.
32. Travis WD, Colby TV, Corrin B, Shimosato Y, Brambilla E. Histological typing of lung and pleura. In: Sobin LH. World Health Organization: international histological classification of tumors, 3rd ed. New York: Springer Verlag, 1999.
33. Jass JR, Sobin LH. Histological typing of intestinal tumours. In: Jass JR, Sobin LH, editors. World Health Organization. International histological classification of tumors, 2nd ed. Berlin: Springer-Verlag, 1989.
34. Schneider A, Borgnat S, Lang H, et al. Evaluation of microsatellite analysis in urine sediment for diagnosis of bladder cancer. Cancer Res. 2000;60:4617-4622.
35. Cave-Riant F, Cuillerier B, Beau-Faller M, et al. Association of genetic defects in primary resected lung adenocarcinoma revealed by targeted allelic imbalance analysis. Am J Respir Cell Mol Biol. 2002;27:495-502.
36. Delattre O, Olschwang S, Law DJ, et al. Multiple genetic alterations in distal and proximal colorectal cancer. Lancet. 1989;12:353-356.
37. Olschwang S, Hamelin R, Laurent-Puig P, et al. Alternative genetic pathways in colorectal carcinogenesis. Proc Natl Acad Sci USA. 1997;94:12122-12127.
38. Sanchez-Cespedez M, Monzo M, Rosell R, et al. Detection of chromosome 3p alterations in serum DNA of non-small cell lung cancer patients. Ann Oncol. 1998;9:113-116.
39. Ookawa K, Sakamoto M, Hirohashi S, et al. Concordant p53 and DCC alterations and allelic losses on chromosomes 13q and 14q associated with liver metastases of colorectal carcinoma. Int J Cancer. 1993;53:382-387.
40. Garcia JM, Silva JM, Dominguez G, Silva J, Bonilla F. Heterogeneous tumor clones as an explanation of discordance between plasma DNA and tumor DNA alterations. Genes Chromosomes Cancer. 2001;31:300-301.
41. Wistuba II, Behrens C, Milchgrub S, et al. Sequential molecular abnormalities are involved in the multistage development of squamous cell lung carcinoma. Oncogene. 1999;18:643-650.
42. Mao L, Lee DJ, Tokmann MS, Erozan YS, Askin F, Sidransky D. Microsatellite alterations as clonal markers for the detection of human cancer. Proc Natl Acad Sci USA. 1999;91:9871-9875.
43. Wang X, Christiani DC, Mark EJ, et al. Carcinogen exposure, p53 alteration, and K-ras mutation in synchronous multiple primary lung carcinoma. Cancer. 1999;85:1734-1739.
44. Massa MJ, Iniesta P, Gonzales-Quevedo R, et al. Differential prognosis of replication error phenotype and loss of heterozygosity in sporadic colorectal cancer. Eur J Cancer. 1999;35:1676-1682.
45. Randhawa GS, Cui H, Barletta JA, et al. Loss of imprinting in disease progression in chronic myelogenous leukemia. Blood. 1998;91:3144-3147.